D.E. Shaw & Co’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.35M | Buy |
+251,069
| New | +$4.35M | ﹤0.01% | 1512 |
|
|
2025
Q1 | – | Sell |
-20,000
| Closed | -$638K | – | 3032 |
|
|
2024
Q4 | $638K | Buy |
+20,000
| New | +$638K | ﹤0.01% | 2300 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 3142 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 3176 |
|
|
2024
Q1 | – | Sell |
-33,086
| Closed | -$1.98M | – | 3115 |
|
|
2023
Q4 | $1.98M | Sell |
33,086
-6,387
| -16% | -$382K | ﹤0.01% | 1741 |
|
|
2023
Q3 | $1.5M | Sell |
39,473
-488,338
| -93% | -$18.6M | ﹤0.01% | 1860 |
|
|
2023
Q2 | $48.1M | Buy |
527,811
+114,958
| +28% | +$10.5M | 0.05% | 274 |
|
|
2023
Q1 | $27.2M | Buy |
412,853
+399,955
| +3,101% | +$26.4M | 0.03% | 465 |
|
|
2022
Q4 | $667K | Sell |
12,898
-184,466
| -93% | -$9.54M | ﹤0.01% | 2605 |
|
|
2022
Q3 | $13.5M | Buy |
197,364
+192,794
| +4,219% | +$13.2M | 0.02% | 748 |
|
|
2022
Q2 | $207K | Sell |
4,570
-28,464
| -86% | -$1.29M | ﹤0.01% | 3382 |
|
|
2022
Q1 | $1.68M | Sell |
33,034
-4,856
| -13% | -$247K | ﹤0.01% | 2545 |
|
|
2021
Q4 | $1.79M | Sell |
37,890
-37,632
| -50% | -$1.78M | ﹤0.01% | 2439 |
|
|
2021
Q3 | $2.49M | Sell |
75,522
-169,507
| -69% | -$5.59M | ﹤0.01% | 1963 |
|
|
2021
Q2 | $15.5M | Sell |
245,029
-91,614
| -27% | -$5.79M | 0.01% | 832 |
|
|
2021
Q1 | $14.4M | Sell |
336,643
-77,419
| -19% | -$3.32M | 0.01% | 849 |
|
|
2020
Q4 | $23.7M | Buy |
414,062
+28,196
| +7% | +$1.61M | 0.02% | 629 |
|
|
2020
Q3 | $11.6M | Sell |
385,866
-145,895
| -27% | -$4.4M | 0.01% | 832 |
|
|
2020
Q2 | $17.4M | Buy |
531,761
+162,028
| +44% | +$5.29M | 0.02% | 634 |
|
|
2020
Q1 | $9.91M | Buy |
369,733
+221,326
| +149% | +$5.93M | 0.02% | 759 |
|
|
2019
Q4 | $4.54M | Buy |
148,407
+137,342
| +1,241% | +$4.21M | 0.01% | 1222 |
|
|
2019
Q3 | $267K | Buy |
+11,065
| New | +$267K | ﹤0.01% | 2313 |
|